title: GLP in safety pharmacology studies: Report card after 15years.
authors.affiliation: Boehringer Ingelheim Pharma GmbH and Co KG, Drug Discovery Support, Biberach an der Riss, Germany; North West University, PreClinical Drug Development Platform (PCDDP), Potchefstroom, South Africa. Electronic address: brian.guth@boehringer-ingelheim.com.
authors.forename: Brian D
authors.initials: BD
authors.lastname: Guth
authors.affiliation: Department of Toxicology & PKDM, Purdue Pharma LP., Cranbury, NJ, 08512, USA.
authors.forename: Michael K
authors.initials: MK
authors.lastname: Pugsley
mesh_terms: D004353:Drug Evaluation, Preclinical / Q000592:standards*; D015507:Drugs, Investigational / Q000009:adverse effects / Q000494:pharmacology; D017408:Guidelines as Topic; D007753:Laboratories / Q000592:standards*; D010601:Pharmacology, Clinical / Q000592:standards*; D018570:Risk Assessment
chemical_list: D015507:Drugs, Investigational
keywords: Good laboratory practice; Safety pharmacology